THERAPEUTIC BENEFIT OF HSP90 INHIBITION IN PULMONARY FIBROSIS

$1,757,427FY2017Department of the ArmyDOD

Childrens Hospital Medical Center

Investigators

View source on USAspending →

THERAPEUTIC BENEFIT OF HSP90 INHIBITION IN PULMONARY FIBROSIS · GrantIndex